Chemical and Biological Weapons Proliferation and Terrorism
With the end of the Cold War, the proliferation of weapons of mass destruction (nuclear, biological, and chemical) replaced the U.S.-Soviet nuclear standoff as the dominant U.S. security concern. Chemical and biological weapons (CBW) proliferation and the potential use of these weapons by terrorists deserve particular attention, as CBW capabilities have been confirmed or suspected in some 20 nations. The anthrax mailings to journalists and members of Congress in 2001 drove home the reality of the bioterrorist threat to U.S. citizens, though evidence of global CBW threats had been mounting for several years. Revelations about the size and sophistication of Iraq's CBW programs in the summer of 1995 provided a disturbing reminder of how advanced such programs can become while avoiding international attention. Iraq's use of chemical weapons in the Iran-Iraq War (1980-88) and Aum Shinrikyo's use of sarin gas in the Tokyo subway on March 20, 1995 suggest that inhibitions on CBW use are not as strong as one might like.
CISAC scholars examine emerging biotechnologies that could be used to cause catastrophic harm, and how to respond to such threats. Working with colleagues at Stanford and other institutions, CISAC researchers are thinking through related public policy issues such as the best ways to strengthen public health surveillance and emergency response, the utility and drawbacks of oversight of research or research publication, and the advantages and dangers of classified biodefense work.
To help clarify our understanding of emerging chemical and biological threats, CISAC addresses the following aspects of these weapons' development and use: production methods for different CBW agents, the effects of CBW agents in humans, different means for dispersing CBW agents (especially in the atmosphere), CBW agent detection, and finally, means for protecting humans (e.g., immunization, evacuation, protective masks and clothing, among others). These technical issues must be addressed in some detail if policymakers are to develop effective responses for limiting the spread of CBW through arms control, deterring their use if they spread, and protecting military forces and civilian populations if deterrence fails.
Contact
Dean Wilkening
Publications
The 5 most recent are displayed. More publications »
- Nuclear Warfare
Dean Wilkening
Academic Press in "Encyclopedia of Violence, Peace, and Conflict", 2nd edition (2008)
Modeling the Incubation Period of Inhalational Anthrax
Dean Wilkening
Medical Decision Making vol. 28, 4 (2008)
Sverdlovsk Revisited: Modeling Human Inhalation Anthrax
Dean Wilkening
Proceedings of the National Academy of Sciences vol. 103, 20 (2006)
Degradation of Biological Weapons Agents in the Environment: Implications for Terrorism Response
Amy L. Stuart, Dean Wilkening
Environmental Science and Technology vol. 39, 8 (2005)
- Biotechnology and Bioterrorism: An Unprecedented World
Christopher F. Chyba, Alexander L. Greninger
Survival vol. 46, 2 (2004)
Events & Presentations
Only 5 recent/upcoming are displayed. More events & presentations »
- Sverdlovsk Revisited: Low-Dose Human Response to Inhalation Anthrax
December 7, 2004 CISAC Science, Technology and Security Seminar
Dean Wilkening - Biological Security: Engaging the Private Sector
November 16, 2004 CISAC Science, Technology and Security Seminar
Michael Moodie, Terence Taylor - Two Bioterrorism Issues: Food Contamination and Anthrax Decontamination
November 9, 2004 CISAC Science, Technology and Security Seminar
Lawrence M. Wein - Medical Logistics for Bioterrorist Attacks
May 25, 2004 CISAC Science, Technology and Security Seminar
Irit Talmor, CISAC Science Fellow - Uncertainties Associated With Biological Weapons Attacks
April 27, 2004 CISAC Science, Technology and Security Seminar
Dean Wilkening, CISAC

